Byung Ho Nam

Effects of a case-based simulation fever management education program for parents of hospitalized children in South Korea: a quasi-experimental study

Byung Ho Nam, Hyun‐Ju Kang

PURPOSE: Because fever is a common symptom in children, parents must have accurate knowledge and management ability about it to be able to provide appropriate management. This study aimed to develop a fever management education program, incorporating case-based simulation practice for parents …

kr (code pays fourni par la source)

P1.11.32 Quality of Life Outcomes from the Phase 3 Study of Atezolizumab + Bevacizumab and Chemotherapy (ATTLAS, KCSG-LU19-04) in EGFR/ALK- Mutated NSCLC

Eun Joo Kang, Sehhoon Park, Taek Min Kim, J-Y. Han et autres

kr, us, Éthiopie, pr, jp (code pays fourni par la source)

Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer

Myong Cheol Lim, Suk‐Joon Chang, Boram Park, Heon Jong Yoo et autres

Importance: Ovarian cancer has the highest mortality rate among gynecologic malignant tumors. Data are lacking on the survival benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in women with ovarian cancer who underwent primary or interval cytoreductive surgery. Objective: To assess the clinical benefit …

kr (code pays fourni par la source)

A Phase 3 Randomized Clinical Trial to Compare Efficacy and Safety between Combination Therapy and Monotherapy in Elderly Patients with Advanced Gastric Cancer (KCSG ST13-10)

Keun‐Wook Lee, Dae Young Zang, Min‐Hee Ryu, Hye‐Suk Han et autres

kr, us (code pays fourni par la source)

Randomized Phase II Study of Axitinib Versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma

Eun Joo Kang, Myung‐Ju Ahn, Chan‐Young Ock, Keun‐Wook Lee et autres

kr, jp, cn, us (code pays fourni par la source)

Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)

In Hae Park, Seock‐Ah Im, Kyung Hae Jung, Joohyuk Sohn et autres

PURPOSE: We investigated whether irinotecan plus capecitabine improved progression-free survival (PFS) compared with capecitabine alone in patients with human epidermal growth factor 2 (HER2) negative and anthracycline and taxane pretreated metastatic breast cancer (MBC). MATERIALS AND METHODS: A total of 221 patients …

kr (code pays fourni par la source)

Incidence and risk factors of missing polyps in flexible sigmoidoscopy: A prospective multicenter study

Ho Yeon Jung, Hyun‐Soo Kim, Hong Jun Park, Dong Il Park et autres

Factors to improve the interobserver agreement for gastric atrophy and intestinal metaplasia: consensus of definition and criteria

Sung Sun Kim, Myeong‐Cherl Kook, Ok‐Ran Shin, Hee Sung Kim et autres

AIMS: Intestinal metaplasia and atrophy of the gastric mucosa are associated with Helicobacter pylori infection and are considered premalignant lesions. The updated Sydney system is used for these parameters, but experienced pathologists and consensus processes are required for interobserver agreement. We sought …

kr (code pays fourni par la source)

Risk prediction model for prostate cancer in a Korean population

Jae Young Joung, S. Kim, Whi‐An Kwon, K.H. Lee et autres

Optimal design and endpoint of clinical trials using immune checkpoint blocking agents

Bhumsuk Keam, Hun Jung, Byung Ho Nam

Immune checkpoint blocking agents (ICBAs) that target either programmed cell death 1 (PD-1) programmed cell death ligand 1 (PD-L1), or cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) have show...

kr (code pays fourni par la source)

ERCC1 Expression-Based Randomized Phase II Study of Gemcitabine/Cisplatin Versus Irinotecan/Cisplatin in Patients with Advanced Non-small Cell Lung Cancer

Ji‐Youn Han, Geon Kook Lee, Kun Young Lim, Young Ju Lee et autres

PURPOSE: We evaluated the clinical utility of excision repair cross-complementation group 1 (ERCC1) expression as a predictive biomarker for platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC). MATERIALS AND METHODS: on days 1 and 8 every 3 weeks) arm. The primary …

kr (code pays fourni par la source)

A Phase II Study of Poziotinib in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma Who Have Acquired Resistance to EGFR–Tyrosine Kinase Inhibitors

Ji‐Youn Han, Ki Hyeong Lee, Sang‐We Kim, Young Joo Min et autres

PurposeWe examined the efficacy of poziotinib, a second-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) in patients with lung adenocarcinoma with activating EGFR mutations, who developed acquired resistance (AR) to EGFR-TKIs. Materials and MethodsThis single-arm phase II study included EGFR-mutant lung …

kr (code pays fourni par la source)